Henry Schein, Inc: Investment in Future Growth and Specialty Business Outlook! 

Henry Schein’s financial results for the fourth quarter and full year of 2023 demonstrated a robust recovery from a significant cybersecurity incident, showcasing the resilience of their business model and the steadfast loyalty of their customers. Notably, Henry Schein reported strong growth in its technology and value-added services businesses, a key strategic focus for the company. Global sales of implants and biomaterials also showed significant growth, largely driven by strategic acquisitions that expanded the company’s offering and market presence. Furthermore, the company’s customers remained loyal, with overall strong relationships between sales consultants, representatives, service technicians, and customers.